May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Quantification of T Cell–Antigen Presenting Cell Interaction in the Iris in a Murine Uveitis Model
Author Affiliations & Notes
  • M.B. Ronick
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • J.T. Rosenbaum
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • S.R. Planck
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • Footnotes
    Commercial Relationships  M.B. Ronick, None; J.T. Rosenbaum, None; S.R. Planck, None.
  • Footnotes
    Support  NIH Grants EY13609, EY10572, EY13093; Research to Prevent Blindness awards to JTR, SRP, and the CEI
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4552. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.B. Ronick, J.T. Rosenbaum, S.R. Planck; Quantification of T Cell–Antigen Presenting Cell Interaction in the Iris in a Murine Uveitis Model . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4552.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : T lymphocytes are educated by antigen–presenting cells (APCs) in secondary lymphoid organs, but the interaction of T cells with APCs at a site of inflammation is less well characterized. Here we report quantification of T cell–APC physical interaction in the inflamed iris in a murine uveitis model.

Methods: : OVA–specific T cells were isolated from spleens of DO11.10 transgenic mice, cultured with OVA323–329 peptide, stained with orange CMTMR and injected IV into three naïve BALB/c mice. After 2–3 days, these mice were challenged with a 4–µl intravitreal injection of 100 µg Alexa Fluor 350 (blue)–conjugated chicken ovalbumin (OVA) and ∼0.5 µg E. coli strain 055:B5 endotoxin. After 24 hours, mice were euthanized immediately following IV injection of FITC–dextran to label blood vessels. Anterior segments were dissected and 3–dimensional image reconstructions were made from Z–stacks of iris regions acquired by 3–color deconvolution fluorescence microscopy. T cell–APC interactions were quantified by determining the percent of infiltrated CMTMR–labeled T cells that were physically contacting probable APCs labeled by uptake of blue OVA. T cells were categorized as one of the following three types: A) T cells in clear, close physical contact with an APC; B) T cells within one T–cell diameter of an APC that may be in contact, though clear cell–cell contact is not visible; and C) T cells not obviously in contact with an APC and greater than one T–cell diameter from the nearest APC. Although the precise number of APCs was difficult to count, the percent of antigen–containing APCs in close contact with at least one T cell was estimated.

Results: : The injection of OVA with endotoxin into the vitreous of BALB/c mice that have received DO11.10 T cells results in reproducible T cell infiltration in the iris in an antigen–specific manner. The replacement of OVA with a control protein results in little or no T cell infiltration in the iris. We found that 22±11% (Mean±SD; n=3 eyes) of infiltrated T cells are in close physical contact with an antigen–specific APC, 36±16% are clearly not in direct contact with an APC, and in 44±6% a definitive conclusion was not clear. Conversely, a substantial number of OVA–labeled APCs appeared to be in contact with an OVA–specific T cell (range: 48%–70%).

Conclusions: : The interaction of T cells with APCs is a fundamental component of the immune response and the visualization of such interactions at a site of inflammation is a novel observation. At the time point tested, a substantial number of T cells in the inflamed irises are affiliated with a probable APC containing the specific antigen recognized by the T cell.

Keywords: uveitis-clinical/animal model • antigen presentation/processing • microscopy: light/fluorescence/immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×